HIV-associated neurocognitive disorder
DB Clifford, BM Ances - The Lancet infectious diseases, 2013 - thelancet.com
Neurological involvement in HIV is often associated with cognitive impairment. Although
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era …
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
People living with HIV are affected by the chronic consequences of neurocognitive
impairment (NCI) despite antiretroviral therapies that suppress viral replication, improve …
impairment (NCI) despite antiretroviral therapies that suppress viral replication, improve …
Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis
Objective To characterize the prevalence and burden of HIV-associated neurocognitive
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study
M Gisslén, RW Price, U Andreasson, N Norgren… - …, 2016 - thelancet.com
Background Cerebrospinal fluid (CSF) neurofilament light chain protein (NFL) is a sensitive
marker of neuronal injury in a variety of neurodegenerative conditions, including the CNS …
marker of neuronal injury in a variety of neurodegenerative conditions, including the CNS …
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Objective: Despite immune recovery in individuals on combination antiretroviral therapy
(CART), the frequency of HIV-associated neurocognitive disorders (HANDs) remains high …
(CART), the frequency of HIV-associated neurocognitive disorders (HANDs) remains high …
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
Background A substantial prevalence of mild neurocognitive disorders has been reported in
HIV, also in patients treated with combination antiretroviral therapy (cART). This includes a …
HIV, also in patients treated with combination antiretroviral therapy (cART). This includes a …
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection
Objective: Mild forms of HIV-associated neurocognitive disorders (HAND) remain prevalent
in the era of combination antiretroviral therapy (cART). Although elevated …
in the era of combination antiretroviral therapy (cART). Although elevated …
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study
Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted
the age distribution of the HIV pandemic upward toward that of the general population. This …
the age distribution of the HIV pandemic upward toward that of the general population. This …
Natural products as anti-HIV agents and role in HIV-associated neurocognitive disorders (HAND): a brief overview
KRV Kurapati, VS Atluri, T Samikkannu… - Frontiers in …, 2016 - frontiersin.org
As the threat of Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency
Syndrome (AIDS) persists to rise, effective drug treatments are required to treat the infected …
Syndrome (AIDS) persists to rise, effective drug treatments are required to treat the infected …